Suchergebnisse - "Menter, Alan"

PubPharm (507)

61

Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios : A Review of the Available Evidence

enthalten in: Dermatology and therapy | 2020

von Wu, J. | Merola, J. | Feldman, S. | +2

ErratumIn: Dermatol Ther (Heidelb). 2020 Aug;10(4):901. - PMID 32419098

62

Correction to: Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence

enthalten in: Dermatology and therapy | 2020

von Wu, J. | Merola, J. | Feldman, S. | +2

63

Correction to: Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence

enthalten in: Dermatology and therapy | 2020

von Wu, J. | Merola, J. | Feldman, S. | +2

64

Correction to: Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence

enthalten in: Dermatology and therapy | 2020

von Wu, J. | Merola, J. | Feldman, S. | +2

65

Importance of Complete Skin Clearance in Psoriasis as a Treatment Goal : Implications for Patient-Reported Outcomes

enthalten in: Journal of drugs in dermatology : JDD | 2020

von Blauvelt, A. | Wu, J. | Armstrong, A. | +3

66

Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence

enthalten in: Dermatology and therapy | 2020

von Wu, J. | Merola, J. | Feldman, S. | +2

67

Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence

enthalten in: Dermatology and therapy | 2020

von Wu, J. | Merola, J. | Feldman, S. | +2

68

Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence

enthalten in: Dermatology and therapy | 2020

von Wu, J. | Merola, J. | Feldman, S. | +2

69

Diffuse dermal angiomatosis of the breast

enthalten in: Proceedings (Baylor University. Medical Center) | 2020

von Nguyen, N. | Silfvast-Kaiser, A. | Frieder, J. | +2

70

Injection Site Reactions in the Federal Adverse Event Reporting System (FAERS) Post-Marketing Database Vary Among Biologics Approved to Treat Moderate-To-Severe Psoriasis

enthalten in: Dermatology and therapy | 2020

von Grace, E. | Goldblum, O. | Renda, L. | +4